Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2023 | Common germline mutations in myelodysplastic syndromes

Rashmi Kanagal-Shamanna • 7 Jun 2023
EHA 2023
Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes

Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines common germline mutations found in patients with myelodysplastic syndromes (MDS) of different ages. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Rashmi Kanagal-Shamanna

1:23
Looking forward to the Cancer Genomics Consortium Annual Meeting
Rashmi Kanagal-Shamanna • 7 Jun 2023
4:06
Incidence of germline mutations in patients with myeloid neoplasms with antecedent solid tumors
Rashmi Kanagal-Shamanna • 7 Jun 2023
1:29
Automated tool for MDS classification using the WHO & ICC classification systems
Rashmi Kanagal-Shamanna • 5 May 2023
5:33
Clinical utility of the homologous recombination deficiency score in AML & MDS
Rashmi Kanagal-Shamanna • 11 Dec 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals